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Typhoid fever (TF) is an acute gastrointestinal infection caused by the bacterium Salmonella 
enterica serotype Typhi (S. Typhi), which is transmitted through contaminated food or 
drinking water from one person to another. Salmonella bacteria is one of the leading causes 
of community-acquired bloodstream infection which record a high mortality rate in sub 
Saharan Africa. High incidence of TF is particularly observed in low income countries in 
sub-Saharan Africa.  
The objective of this study is to estimate the incidence of TF in Ouagadougou Burkina Faso.  
Two regions within the capital city Ouagadougou, Nioko and Polesgo, were selected to carry 
out a population-based prospective febrile surveillance which took place between 2015 and 
2016.  
Participants residing in these two areas and who presented with acute fever 38C, using 
tympanic temperature records were enrolled into the study. Participants with a history of 
fever more than 72 hours and <38C and those leaving out of catchment area were excluded 
from the study. Blood samples were collected from participants and a blood culture was 
conducted to confirm bacteremia. The results of 1,306 blood culture conducted confirmed 21 
samples positive for Salmonella bacteria between 16 June 2015 and 25 April 2016 of which 9 
were S. Typhi infections. 
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Two cases were found in children less than 5 years old three cases in the group between 6-15 
years. The incidence of S. Typhi overall was calculated to be 125 per 100,000 person years of 
observation (PYO) with highest prevalence seen in children <5 years.  
        The prevalence of Multi- drug resistant (MDR) S. Typhi isolates, defined as resistance 
to three or more classes of antibiotics, was high (7/9).  
Administration of an effective typhoid fever vaccine in children under 5 years of age may be 
an effective strategy to reduce the burden of TF in Burkina Faso. Further studies 
characterizing the severity of S. Typhi infections, including the development of intestinal 






        Typhoid fever (TF) is an acute gastrointestinal infection caused by the 
bacterium Salmonella enterica serotype Typhi (S. Typhi), which is transmitted through the 
fecal-oral route with contaminated food or drinking water from a sick person or healthy 
carrier to another person. (Park, 2015) (Baker, Hombach, & Marks, 2016)(Steele et al., 2016) 
TF is characterized by an onset of high fever, extreme fatigue, headache, constipation, chills, 
and muscle pain. Other symptoms include: an enlarged liver, lack of appetite, and some 
patients may present with diarrhea and vomiting, a rash on their trunk.(Steele et al., 2016) 
Symptoms of TF can be noticed 1 to 3 weeks after exposure to the S. Typhi bacteria, and 
severe symptoms such as confusion, intestinal hemorrhage, perforation, delirium, may be 
noticed 2 to 3 weeks after onset of the illness based on bacteria multiplication in the intestinal 
tract of the affected individual.(Andrade & Andrade, 2016) 
         TF remains a significant contributor to global mortality and morbidity which is a 
leading cause of community-acquired bloodstream infection in sub Saharan Africa. A recent 
estimate of global incidence is in between 11 million and 18 million cases annually, with a 
mortality rate estimated between 128,000 and 190,200 deaths per year. (Crump & Chb, 2017) 
The incidence of TF in sub Saharan African is 100 per 100,000 PYO with 33,490 deaths 
about 26.0% of global Typhoid deaths. (Mogasale et al., n.d.) (Crump & Heyderman, 2019) 
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The incidence of TF in Burkina Faso remains very high with 383 per 100,000 PYO. (Marks 
et al., 2017)  
        In most Low and middle income countries (LMIC) little or no surveillance programs and 
information on incidence and burden of the TF exist so there is high need to carry out studies 
in sub Saharan Africa such as Burkina Faso. (Baker et al., 2016) 
Burkina Faso is a country in West Africa sharing boundaries with Mali in the north, Ghana 
and Togo in the south, Ivory Coast in the southwest, Niger in the east and Benin in the 
southeast. Burkina Faso has a land surface that covers an area of about 274,200 square 
kilometers. The capital city is Ouagadougou and their official language is French but there 
are over 70 languages spoken.   
           Doing a study on clinical surveillance of febrile patients and incidence of S. Typhi in 
the catchment area will provide information on the burden of disease to the health policy 
makers to act by introducing a TF mass vaccination campaign or by improving on Water, 
sanitation and hygiene (WASH) in the affected areas. The administration of TF vaccine in 
the catchment area of Ouagadougou will immunize the population against invasive S. typhi 
which will greatly reduce the number of TF cases that will occur through transmission from 
person to person. The drop in TF cases in the community will reduce the number of sick 
persons thereby reducing the prevalence of premedication at home by the population. (Marks 
et al., 2017) Premedication is common in Africa due to the fast-growing rate of over-the-
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counter drugs which are cheaper. This drop in the number of TF cases will equally reflect on 
the fall in the prevalence of MDR due to abusive use of antibiotics at home and misused in 
hospitals because of poor diagnosis. 
1.2. Goal 
          The goal of this study is to determine the burden of S. Typhi infection in the catchment 
area of Nioko and Polesgo in Ouagadougou, Burkina Faso. 
1.3.  Objectives  
        We will determine the incidence of TF and characterized the population at risk in the 
catchment area. The prevalence of MDR to first line antibiotics will be measured and assess 
the frequently used antibiotics or analgesics by participants as premedication before visiting 





LITERATURE REVIEW  
 
2.1. Review on burden of the disease 
         Global Burden of typhoid and paratyphoid fever morbidity is estimated at 15.5 million 
with about 154,000 deaths in 2016.(Marks et al., 2017)  Another TF estimated incidence in 
west Africa is about 10–100 cases per 100,000 person-years of observation (PYO) that occurs 
mostly in urban areas with high population densities(Marks et al., 2017)(Bill & Foundation, 
2017). 
          Estimated global incidence of 14·3 million cases of typhoid and paratyphoid fevers 
occurred in 2017 giving a 44·6% drop from 25·9 million cases in 1990. 76·3% of enteric 
fever was caused by S. Typhi with a global case fatality estimated at about 0·95% in 2017. 
This case fatality was higher among children than older adults living in lower-income 
countries. (Bill & Foundation, 2017) A recent estimate of global incidence TF is between 11 
million and 18 million cases annually, with a mortality rate estimated between 128,000 and 
190,200 deaths per year. (Crump & Chb, 2017) 
           Incidence rate from confirmed invasive Salmonella infections were estimated using 
Adjusted incidence rates (AIRs) per 100,000 PYO in the catchment population. Calculated 
PYO in catchment area was by projecting the study population from the start to the end of 
recruitment period using annual growth rates of the country. (Kalckreuth et al., 2016) 
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          Adjusted incidence rates (IRs) were estimated from confirmed invasive Salmonella 
infections in catchment populations per 100,000 person-years of observation (PYO) and from 
incidences of previously published documents. All resident patients in the catchment area 
contributed to PYO and their contribution ended when the person no longer stay or died 
during the surveillance period for HDSS sites. The annual population growth rate of the 
country was used to calculated PYO by projecting the population of the catchment area from 
the beginning to the end of the study period. (Kalckreuth et al., 2016) 
MDR S. Typhi isolated is an increasing problem in the world especially in south and 
southeast Asia for decades with H58 strain which is migrating to African countries. (Marks et 
al., 2017) This strain might cause TF in previously absent geographical areas and such strains 
might stimulate the use of antibiotics to increased where it is bought over the counter or 
available without any prescription because S. Typhi respond more slowly to antibiotic 




2.2. Review on antimicrobial resistance to antibiotics 
           MDR strains will increase TF disease burden in LMIC due to the lack of high-quality 
diagnostic equipment and misuse of antimicrobial drugs. This scale of antimicrobial 
resistance is a problem that will gradually grow as years pass by and this has been observed 
in sub Saharan Africa (Baker et al., 2016).(Fever & Overview, 2011). Given the widespread 
use of antimicrobials in sub-Saharan Africa, additional data from Ouagadougou, Burkina 
Faso, which has good laboratory-based diagnostic capacity for detecting bacterial antibiotic 




2.3. Review on diagnosis of typhoid fever 
           Limitations in diagnosis in most rural areas with poor water quality, hygiene and 
sanitation (WASH), restricted access to medical care, overcrowding, will be a problem in 
assessing the burden of invasive Salmonella disease. This inability to diagnose patients in 
those areas will underestimate the burden of invasive Salmonella disease and increasing 
incidence of the disease. (Baker et al., 2016) 
           The incidence of TF in many parts of Africa has been underestimate due to difficulties 
in microbial culture of the disease leading to substantial disease burden. (Dougan, n.d.) 
           Many countries are still uncertain with the true disease burden for S. Typhi infection 
due to little or no surveillance or systematic hospital-based surveillance. This bad situation is 
worsen with the lack of accurate rapid diagnostic kits, poor disease reporting systems, no 
frequent laboratory testing, and clinical diagnosis of typhoid is often difficult due the 
occurrence of more than one febrile illness in the same patient such as dengue or malaria 




2.4. Review on control and prevention of typhoid fever 
                Many multilateral donors have developed a better and easier to use diagnostic tests 
without the use of cumbersome techniques to diagnose typhoid in rural area and the test can 
be performed at any point in time. They also introduce preventive vaccination against S. 
Typhi infections to targeted remote areas in order to reduce the disease burden (Steele et al., 
2016). This move will facilitate the diagnosis of TF in rural areas where TF is endemic for 
effective management and prevention of disease spread to other persons. The effectiveness of 
TF vaccine usage is one of the preventive measures against invasive Salmonella disease in 
high risk zones which must be implemented by policymakers to reduce the incidence that 
affects mostly the younger age groups in rural areas with low population density. (Marks et 
al., 2017)  
                  Studies have shown that good knowledge, attitude and practice of WASH such as 
washing of hands after visiting the toilet, wash fruits before eating, drink good water and 
mass vaccination with the new TF conjugate vaccine will reduce the burden of the invasive 
Salmonella disease thereby reducing the incidence of MDR.(Al-emran et al., 2016) 
Contaminants organisms included non-pathogens like bacteria, fungi, Coagulase- negative 
Staphylococci (CNS), Hey Bacillus, which are not associated with bloodstream infections but 
commonly associated with skin microbiota may mask the S. Typhi. (Marks et al., 2017) 
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Invasive Salmonella disease is one of African agenda top public health priority disease which 
will be eliminated with the development of typhoid fever conjugate vaccines and its 
administration to the endemic area of high incidence of typhoid fever. The TF community 
needs to tackle the political issues surrounding TF immunization now if they believe that 
regional elimination of S. Typhi is a tangible target. (Baker et al., 2016)(Article, 2016) 
             The introduction of S. Typhi infection vaccine in to the immunization calendar of 
children under 5 years of age will have a greater effect in reducing the disease incidence in 
children under the age of 5 years particularly in children less than 2 years who are affected 













3.1. Study site 
         This study was carried out within the Nioko and Polesgo health areas in the north of 
Ouagadougou Burkina Faso. The site was included in this study because of evidence from 
previous TF reports in the surveillance conducted by the Typhoid Fever Surveillance in 
Africa Program (TSAP), laboratory infrastructure suitable for blood culture with experience 
microbiological laboratory staff, and access to a functional health and demographic 
surveillance system (HDSS) in the target area. 
3.2. Study Design  
        This is a population-based prospective febrile surveillance using data between 16 June 
2015 to 25 April 2016 of Kossodo Health Center a public health unit which serve patients of 
all ages in Nioko and polesgo health area of north Ouagadougou Burkina Faso. Blood culture 
test in combination with malaria parasite test was also done using a rapid diagnostic test with 
the blood sample in order to have a differential diagnosis.  
3.3. Study population 
         Recruitment was opened to all 28,701 inhabitants of the catchment area  but a  the 
section criterial was made such as any person with high temperature ≥38.0°C, visiting the 
Kossodo health center during the study period from 16 June 2015 to 25 April 2016 and were 
staying in the catchment area were enrolled into the study, and those with a history of fever 
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more than 72 hours and <38C, as well as patient resident out of catchment area were 
excluded from the study (Mark et al.,2017). 
3.4. Sample size  
         Blood samples were collected from 1,306 persons who made the enrollment criterial 
and a blood culture test was performed for each person.  
             Statistical analysis 
          Isolation test for MDR was done to know the prevalence of drug resistance within S. 
typhi bacteria in the catchment area. Participants consent were obtained for eligible 
participants before enrollment and collection of blood samples.   
Data was obtained and the results were analyzed in tables and figures, these results were used 
to estimate the incidence of typhoid fever in the Burkina Faso. The incidence of S. Typhi also 
known as rate is been calculated by the total number of new cases of TF (numerator) divided 
by the population at risk (denominator) from the beginning of the observation period usually 
for a year and the unite express per 100,000 person per year of observation. (Dvm, 2017)  
 Incidence rate = the total number of new cases  X 100,000. 
                              the population at risk  
Incidence rate from confirmed invasive Salmonella infections were estimated using Adjusted 
incidence rates (AIRs) per 100,000 PYO in the catchment population. Calculated PYO in 
catchment area was by projecting the study population from the start to the end of recruitment 
period using annual growth rates of the country. 
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             Assumptions in the calculation of S. Typhi in Burkina Faso Some assumptions were 
made to calculate incidence rate of S. Typhi in participants who were enrolled in the study. 
The first assumption was that the blood culture sensitivity test was only 50 % sensitive 
meaning that 50% of positive cases were missed during testing. The second assumption was 
that just 50% of the eligible population was enrolled due to limited capacity for enrollment. 
For those participants who either sick but with low temperatures were excluded and even 
those sick but not living in the catchment area were equally excluded from the study.  
          This number of positive cases were augmented considering that all participants who 
were sick and seeking healthcare services were enrolled in the study with their blood samples 
collected for culture test. Another consideration was that participants who took auto 
medications before visiting the health structure will not have any influence on the blood 
culture sensitivity test due to pre-medication with antibiotics results in lower sensitivity of 
blood culture. 
            We used same age group range from Mark et al 2017 which is the range mostly used 







             During the one-year period of this study, 1,306 participants were enrolled from the 
catchment area. The results are presented in tables and figures with records showing more 
recruitment of women, 740/1,304 (56.74%) compared to men. Information on sex was 
unavailable for two participants. The most represented age group was children below 5 years 
of age 426/1,306 (32.62%) followed by aged 6-15 years old 285/1,306 (21.82%)  
Table 1: Distribution of participants who consulted with symptoms by Age range  
 
Age range (years) Frequency Percentage (%) 
< 2  203 15.54 
2-5 223 17.08 
6-15 285 21.82 
16-25 260 19.91 
26-35 211 16.15 
>36 124 9.49 
Total 1,306 100.00 
 
The most frequent symptoms in addition to fever on presentation were headache (703/1,306) 
participants, abdominal pain (440/1,306) participants, and vomiting (336/1,304) participants.  
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Table 2: Presenting Symptoms of patients during consultation by age range 
Symptoms 















pain 14 82 110 139 95 440 33.69 
Headache 14 66 200 262 161 703 53.83 
Constipation 1 2 4 13 7 27 2.10 
Vomiting 11 70 105 98 52 336 25.72 
Diarrhea 14 72 15 31 15 147 11.25 
Cough 17 104 35 32 25 213 16.31 
Sore throat 0 1 4 8 6 19 1.45 
Running nose 15 73 31 32 20 171 13.10 
Rash 2 8 5 6 1 22 1.68 
Total 88 478 509 621 382 2,078 100.00 
 
 
             Auto medication at home is a growing phenomenon in most underdeveloped 
countries due to lack of finances to obtain proper medical attention. Out of 1,306 participants 
enrolled 721 took pre-medication and 75 of then used antibiotics and the most commonly 
used antibiotics was Cotrimoxazole 24/75 participants recorded. This high used of 




bacterial infection and malaria parasite together. Another highly consumed drug was 
penicillin with 23/75 participants. On the other hand, oral cephalosporins was used by 1 
participant at home which is a third line drug reserve for treatment in case of drug resistance. 
Tetracycline was also used by1 participant as auto medication which is a broad-spectrum 
antibiotic. In general, 75 participants used antibiotics before consulting and 3 of those 
participants took more than one type of antibiotic. 
              Analgesics recorded a similar number of consumptions (721) at home by participants 
and this was common within the under 5 years of age (271/721) participants before seeking 
medical attention.  More participants (721) took analgesics against those who took antibiotics 





Table 3: Reported antibiotic and analgesic use from 75 participants reporting usage prior to 














Antibiotic Total 15 15 13 8 17 7 75 
Penicillin 4 4 5 4 4 2 23 
Oral 
cephalosporins 
0 1 0 0 0 0 1 
Erythromycin 1 0 0 0 0 2 3 
Doxycycline 
(Tetracycline)   
0 1 0 0 0 0 1 
Ciprofloxacin 0 1 0 0 6 1 8 
Metronidazole 3 2 2 1 4 0 12 
Cotrimoxazole  7 5 5 3 3 1 24 
Others 0  1 1 0 0 1 3 





4.2. Laboratory results 
             This result was obtained from 1306 blood cultures performed between 16 June 2015 
to 25 April 2016 in the laboratory and were classified into two categories; pathogens and 
contaminants. 84 pathogens were found positive in blood samples cultured with 
Staphylococcus Aureus 45/84 leading the positive number which is the causative bacteria for 
sore throat, and this was be reflected in children less than 5 years of age with 25 out of 45 
Staphylococcus Aureus found in blood culture. The next pathogen with a high number was S. 
Typhi recording 9/84 positive blood cultured samples. Out of the 9 positive samples for TF, 3 
positive cases were from the age range 6-15 years and 2 of those positives were from children 




Figure 1: The different pathogens recorded in blood samples of participants 
 
 
           The 9 positive cases of S. Typhi isolates cultured from the blood samples of 1,306 
febrile participants were used to calculate the incidence rate of S. Typhi in the catchment 
area. 
Incidence = number of new cases divided by the population at risk over a time period of one 




Table 4: Adjusted incidence rate for S. Typhi 




rate (per 100,000 
PYO) 
All ages 1,306 28,701 9 31.35 125.43 
<2 years 203 4,462 1 22.41 89.64 
2-5 years 223 4,900 1 20.41 81.63 
6-15 years 285 6,263 3 47.90 191.00 
16-25 years 260 5,714 2 35.00 140.00 
26-35 years 211 4,636 2 43.14 172.56 
>36 years 124 2,726 0 0.00 0.00 
 
             This result indicates that for every 100,000 people per year of observation 31 of them 
are affected with typhoid fever. Taking the assumptions in consideration, were blood culture 
test is 50% efficient, then 50% of positive results are missed. So 2x9 positive cases for S. 
Typhi =18. 
With the other assumption of just 50% of population consulted and had 18 positive cases, and 
if 100% of participants are enrolled in the study, then the positive case will be 2x18= 36. 
For the incidence will be = 36/28,701 x 100,000 
                                =125per 100,000 person-year of observation. The method used to 
calculation of the AIR for the total number of cases apply to all the different age ranges. 
For every 100,000 persons in the community 125 persons are affected with the typhoid fever.  
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Coagulase negative Staphylococci (CNS) was the most prevalent contaminant 122/173. This 
CNS contaminant is well known for negative influence on bacterial in the blood stream.  
 
Table 5: Bacteria and contaminants identified in blood samples of participants during 
Laboratory testing. 
 













Pathogens Total 24 18 15 10 11 6 84 
E coli 1 1 0 0 2 2 6 
Non-Tyhpoid 
Salmonella  
3 2 0 0 3 0 8 
Salmonella 
Typhi 
1 1 3 2 2 0 9 
Salmonella 
Para typhi B 
2 1 0 1 0 0 4 
Pseudomonas 
Aeruginosa 
0 0 1 1 0 0 2 
Staphylococcus 
Aureus 
14 12 11 5 1 3 45 
Other 
pathogens 
3 2 0 1 3 1 10 
Contaminants Total 50 39 33 13 17 21 173 
Bacillus  8 5 15 4 7 11 50 
CNS 42 34 17 9 10 10 122 
Viridians 
Streptococci 
0 0 1 0 0 0 1 
 
             Multi-drug resistance was defined as bacteria resistance to 3 or more different classes 
of antibiotics. From Table 6 shows the occurrence of MDR S. Typhi isolates to three groups 
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of antibiotics; the beta-lactams (Penicillin and Amoxicillin) class, antihistamines 
(Chloramphenicol) class and sulfonamides (Cotrimoxazole) class of antibiotics. In more 
detail, a total of 7 S. Typhi isolates were resistant to three different classes of antibiotics, 3 
isolates of Salmonella Typhi were resistant to Cotrimoxazole, while 3 other Salmonella 
Typhi isolates were resistant to the Penicillin’s and Amoxicillin, while 1 isolate of S. Typhi 
was resistant to Chloramphenicol. 
Another bacterium that had resistance was E. coli with 4 isolates resistant to Cotrimoxazole. 
Other pathogens like; 5 Salmonellae (NTS) isolates, 14 Staphylococcus Aureus isolates, 2 
Salmonella Para typhi B isolates, and 3 S. Typhi isolates were all resistant to Cotrimoxazole. 
Staphylococcus Aureus isolates were the only isolates that had resistant to all the different 




Table 6: Antimicrobial profile of isolated bacteria resistance to antibiotics. 
 
Drug Amoxicillin Ceftazidime Cefuroxime Chloramphenicol Cotrimoxazole Penicillin 
E. coli 4/8 1/8 2/8 0 4/8 2/8 
Salmonellae 
(NTS) 
3/8 0 0 3/8 5/8 2/8 
Salmonella 
Typhi 
1/9 0 0 1/9 3/9 2/9 
Salmonella 
Paratyphi B 
1/4 1/4 0 1/4 2/4 1/4 
Pseudomonas 
aeruginosa 
1/2 0 0 1/2 0 0 
Staphylococcus 
Aureus 
5/46 2/46 4/46 6/46 14/46 6/46 





           The results of blood test using the malarial rapid test for 1,306 participants, recorded 
576 positive malaria parasites in 1300 blood samples approximately 44.3%, indicative of 
high malaria prevalence in the catchment area as seen on Table 6. Results from 6 blood 
samples were not recorded due to missing registration information.  
 





Positive 576 44.3% 
Negative 724 55.7% 























       S. Typhi was identified as the primary cause of invasive bacterial infection higher among 
children under the ages of 15 years old with a total score of 5/9 positive samples and 2 of 
these positives were in children less than 5 years old in Nioko and Polesgo catchment area in 
Ouagadougou, Burkina Faso. Results from previous studies suggest that Typhoid fever in 
some sub-Saharan Africa settings occurs predominately in urban settlements with high- 
population densities, and that disease incidence could have been overestimated using the 
Widal test(Balasubramanian et al., 2018). This study was carried out in a semi urban setting 
which indicated a high incidence of Typhoid fever in areas with high-population densities.  
           The results of this study show that 125 cases per 100,000 PYO is higher than the 
estimated burden of S. Typhi infection in Africa which affect mostly children under the ages 
of 15 years in Ouagadougou, Burkina Faso. These estimates were not valid to my opinion 
because comparing two estimates from two different studies is difficult to have a correct 
estimate due to many factors put in place by Marks et al., with same protocol and in same site 
which does not match each other. The method used in those studies to calculate the 
population were different which will give different results at the end but to prevent this high 
incidence of typhoid fever the population need good access to safe drinking water and 
improved sanitation as well as effective treatment options of S. Typhi infection. The use of 
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new TF conjugate vaccines for immunization against TF might provide more powerful tools 
for disease control.  
             E coli and Staphylococcus aureus were also most frequent non-Salmonella pathogens 
isolated from blood culture of participants. Malaria prevalence was also high in the 
catchment area that double the nature and burden of disease affecting the under 15 years of 
age with the impact more on the under 5years old. 
Results of this study also identified a high prevalence of resistance against first-line 
antimicrobials in S Typhi infections as seen on Table 6. Cotrimoxazole and Penicillin were 
the drugs that recorded high prevalence of resistance by the S. Typhi and these same drugs 
also recorded a high consumption as premedication at home by the participants due to the 
availability, cheap and their broad-spectrum nature to treat bacterial infection. 
            Doing a study in the catchment area had some motivating factors such as; a well-
established laboratory and qualified microbiology technical staff to do a reliable and quality 
blood culture test which will make the results of the study more reliable. The geographical 
location and accessibility of the health structure greatly influences all types of participants to 
seek for health interventions thereby increasing the number of participants who are eligible 
for enrollment into the study. This study enrolled a small population size for convenient in 
order to achieve quality and reliable results thereby gaining time. 
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                 The use of a blood culture test in the laboratory to diagnose TF was a motivating 
factor for good results because it is the most reliable test to diagnose Typhoid than those that 
were using Widal test to diagnose Typhoid. 
With the motivating factors that had great positive influence to this study, there were equally 
some limitations to this study that had a negative feedback being that majority of the blood 
isolate tests for drugs resistance were Not performed which could give a much better result of 
drug resistance in the catchment area. This led to under reporting of the prevalence of drug 
resistance in the study site. 
Using blood culture as the most reliable test to diagnose typhoid fever was not 100% efficient 
implying that 50% of the number of positive cases were missed thereby under reporting the 
prevalence and incidence of the disease.  
                 The study time was limited to about one year which cannot reflect longer 
epidemiological trends. Auto medication by some participants also play a greater role to 
reduce blood culture sensitivity thereby masking the disease and excluding some participant 
whose temperatures were low during the time of enrollment. All these poor diagnoses and 
auto medication could lead to misused of drugs thereby leading to drug resistant which is 
global treat.  
       This study was carried out in a small area having a small population which did not cover 
the whole region leading to few numbers of cases from the community resulting to false 
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incidence of Typhoid fever. The population used was an estimated population from marks et 
al in 2017 because that same site is also involved in the HDSS. This estimated population 
greatly influence the results positively by increasing the incidence of typhoid fever in 
Burkina Faso. 
Strengthen  
        The study site had a well-established laboratory and qualified microbiology technical 
staff to perform blood culture. 
The study population was well described due to enrollment in a health and demographic 
surveillance system (HDSS) 
Weakness 
          Blood culture sensitivity test was assumed to be 50% sensitive giving rise to 
underestimation of typhoid fever cases. 
We did very simple calculations for the AIR that did not account for 95% confidence interval 
thereby giving uncertainty in the calculations. 
           The study time was limited to one year which make it unable to detect long-term 




          S. Typhi bacteria is a bloodstream infection found mostly in children below 15 years of 
age with a greater impact felt in the under 5 years old children in Ouagadougou, Burkina 
Faso. This age group is considered by WHO as a risky population. Results from Marks et. al 
2017 study have shown that Typhoid fever vaccine in highly effective in affected areas and 
will greatly reduce the bacteria incidence of typhoid fever in the catchment area. Other 
studies hold that improved sanitation, safe drinking water as well as effective treatment 
options of S. Typhi infection will greatly reduce the spread of the disease. 
              Considering the assumptions and weaknesses of this study in the estimation of 
incidence rate of Typhoid fever in Ouagadougou we might give contradicting incidence of S. 
Typhi which is not real situation of the disease so; further studies in additional sites and 
different settings are required in order to generate evidence supporting a national campaign 
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